First Battalion™ Universal Spacer System Surgical Case Completed in the U.S.
Featured at NASS Booth #1147
CARLSBAD, Calif., Oct. 12, 2015 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that the first surgical case utilizing the Battalion Universal Spacer System in the U.S. has been successfully completed. Battalion features polyetheretherketone (PEEK) implants that are titanium-coated for potential osseointegration. The Company will be showcasing Battalion, as well as its portfolio of products at the upcoming North American Spine Society (NASS) Annual Meeting being held at McCormick Place West, Chicago, Illinois, from October 14th – 16th, 2015. Alphatec Spine will be located in booth number 1147.
Bret Abshire, M.D., a board-certified neurosurgeon specializing in back and neck care in Temecula, California, successfully utilized the Battalion Universal Spacer System through a transforaminal lumbar interbody fusion (TLIF) approach in a recent surgical procedure. “Battalion provides a major improvement over other interbody systems available today,” commented Dr. Abshire. “The combination of using a PEEK cage, coated with titanium results in a strong product offering unique conditions for potential bone in-growth and improved patient outcomes. For surgeons, the Battalion system features innovative instrumentation for disc prep, access and implantation and the ergonomic design provides enhanced tactile feel and comfort throughout both dry and wet conditions of surgery.”
The comprehensive Battalion Universal Spacer System supports spinal fusion procedures in skeletally mature patients with degenerative disc disease. This unique system includes both straight and curved implants for posterior lumbar interbody fusion (PLIF) and TLIF, as well as upgraded instrumentation for posterior disc preparation. All implants are coated with a thin layer of titanium coating over PEEK and designed to resist migration during the procedure. Battalion implants are available in a wide variety of sizes to support varying patient anatomies and surgeon needs. In addition, the Battalion instrument set was thoughtfully designed to enhance the surgeon experience through ergonomic instrumentation aimed at supporting procedural efficiency and improving control throughout the insertion process. A key example of this is the Battalion Inserter, which features quick loading and unloading of the implant with a simple 180-degree turn.
“Battalion represents another milestone in the transformation of our product portfolio and pipeline,” said Jim Corbett, President and Chief Executive Officer of Alphatec Spine. “Battalion’s next-generation titanium-coated implants and new instrumentation was designed for surgeons who are looking to optimize their spinal fusion procedures and enhance patient outcomes. Looking forward, Battalion provides us with the opportunity to compete more effectively in what we estimate to be a $1.5B global interbody market.”
About Alphatec Spine
Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is a global medical device company that designs, develops, manufactures and markets spinal fusion technology products and solutions for the treatment of spinal disorders associated with disease and degeneration, congenital deformities and trauma. The Company’s mission is to improve lives by delivering advancements in spinal fusion technologies. The Company and its affiliates market products in the U.S. and internationally via a direct sales force and independent distributors.
Additional information can be found at www.alphatecspine.com.
About the North American Spine Society (NASS)
The North American Spine Society is a global multidisciplinary medical society that utilizes education, research and advocacy to foster the highest quality, ethical, value-based and evidence-based spine care for patients. The society is comprised of almost 9,000 members worldwide from disciplines including orthopedic surgery, neurosurgery, physical medicine and rehabilitation, pain management, physical/occupational therapy, anesthesiology, radiology and other health care professionals focused on the spine.
Additional information can be found at www.nassannualmeeting.org.
Forward Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management’s current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Alphatec Spine cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors. Forward-looking statements include the Company’s ability to achieve profitable growth; the Company’s ability to achieve both domestic and international growth and future profitability. The words “believe,” “will,” “should,” “expect,” “intend,” “estimate” and “anticipate,” variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. The important factors that could cause actual operating results to differ significantly from those expressed or implied by such forward-looking statements include, but are not limited to; the uncertainty of success in developing new products or products currently in Alphatec Spine’s pipeline within forecast timeframes, or at all, including without limitation the products discussed in this press release; failure to achieve acceptance of Alphatec Spine’s products by the surgeon community or hospitals, including without limitation the products discussed in this press release; whether the Battalion Universal Spacer System and its features provide an improvement over systems available today; Alphatec Spine’s ability to develop and expand its U.S. and/or global revenues; continuation of favorable pricing or third-party payor reimbursement for procedures performed using Alphatec Spine’s products, including the products discussed in this press release; unanticipated expenses or liabilities or other adverse events affecting cash flow or Alphatec Spine’s ability to successfully control its costs or achieve profitability; uncertainty of additional funding; Alphatec Spine’s ability to compete with other competing products and with emerging new technologies; product liability exposure; an unsuccessful outcome in any material litigation in which the Company is a defendant; patent infringement claims and claims related to Alphatec Spine’s intellectual property. Please refer to the risks detailed from time to time in Alphatec Spine’s SEC reports, including its Annual Report Form 10-K, as well as other filings on Form 10-Q and periodic filings on Form 8-K. Alphatec Spine disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.
CONTACT: Investor/Media Contact: Christine Zedelmayer Investor Relations Alphatec Spine, Inc. (760) 494-6610 email@example.com